Sandoz And Polpharma Strike Global Deal For Natalizumab

 
• By David Wallace
  
polpharma
Polpharma has licensed natalizumab rights to Sandoz • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business